TCL Archive In Brief: FASEB Recommends $11.75 Billion NIH Budget; Natcher Wins House Appropriations Chairmanship December 11, 1992
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005